Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies

Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies

Bibliographic Details
Main Authors:	M. Nonnemacher, W. Dampier, M. Desimone, V. Pirrone, K. Kercher, S. Passic, J. Williams, B. Wigdahl
Format:	Article
Language:	English
Published:	Elsevier 2015-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020313479

Similar Items

PP 6.5 – 00205 Utilization of high-throughput assays and deep-learning for selection of CRISPR/Cas9-gRNA pairs used in an HIV-1 cure strategy
by: R. Berman, et al.
Published: (2022-12-01)

HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients.
by: Will Dampier, et al.
Published: (2016-01-01)

PP 1.43 – 00206 Evaluating integrated HIV-1 quasispecies using Near Full Length sequencing in ART-suppressed individuals in the Drexel CARES Cohort
by: M. Collins, et al.
Published: (2022-12-01)

Designing broad-spectrum gRNAs to target the HIV-1 LTR with CRISPR/cas9-based therapeutic strategies
by: A. Allen, et al.
Published: (2017-12-01)

Computational detection of off-target effects of CRISPR/Cas9-associated gRNAs
by: W. Dampier, et al.
Published: (2015-12-01)

Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
by: Neil T. Sullivan, et al.
Published: (2020-08-01)

Broad-spectrum gRNAs abolish HIV-1 LTR-mediated transcription in cells that receive CRISPR/Cas9 therapy
by: B. Wigdahl, et al.
Published: (2019-12-01)

Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy
by: Andrew Atkins, et al.
Published: (2021-08-01)

CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5’ long terminal repeats to permanently inactivate latent provirus
by: B. Wigdahl, et al.
Published: (2019-12-01)

HIV-Quasipore: A Suite of HIV-1-Specific Nanopore Basecallers Designed to Enhance Viral Quasispecies Detection
by: Robert W. Link, et al.
Published: (2022-05-01)

Computational analysis of cas proteins unlocks new potential in HIV-1 targeted gene therapy
by: Will Dampier, et al.
Published: (2024-01-01)

Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites
by: Cheng-Han Chung, et al.
Published: (2020-09-01)

Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9
by: Alexander G. Allen, et al.
Published: (2023-04-01)

Genetic variation continues to occur in well-controlled HIV-1-infected patients
by: W. Dampier, et al.
Published: (2015-12-01)

HIV-1 Tat Length: Comparative and Functional Considerations
by: Anthony R. Mele, et al.
Published: (2020-03-01)

Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy
by: Cheng-Han Chung, et al.
Published: (2021-03-01)

Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals.
by: Ashley Azar, et al.
Published: (2016-01-01)

Examining functional alterations of HIV-1 Tat variants associated with neurocognitively impaired patients in the Drexel Medicine CARES Cohort
by: M.R. Nonnemacher, et al.
Published: (2017-12-01)

SNPs within the HIV-1 LTR associate with increased virus persistence
by: N.T. Sullivan, et al.
Published: (2015-12-01)

CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.
by: Satinder Dahiya, et al.
Published: (2014-01-01)

Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1
by: Pirrone Vanessa, et al.
Published: (2012-01-01)

Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection
by: Alexander G. Allen, et al.
Published: (2018-12-01)

Pre-S Deletions are Predominant Quasispecies in HIV/HBV Infection: Quasispecies Perspective
by: Nie Y, et al.
Published: (2020-06-01)

HIV- Bidirectional Encoder Representations From Transformers: A Set of Pretrained Transformers for Accelerating HIV Deep Learning Tasks
by: Will Dampier, et al.
Published: (2022-05-01)

Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.
by: Benjamas Aiamkitsumrit, et al.
Published: (2014-01-01)

Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
by: Yan Feng, et al.
Published: (2016-08-01)

HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity.
by: Michael R Nonnemacher, et al.
Published: (2016-01-01)

Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
by: Wu, Xuebing, et al.
Published: (2015)

Characterization of C/EBP Binding Sites Downstream of the Transcriptional Start Site in the HIV-1 LTR
by: Wigdahl Brian, et al.
Published: (2005-12-01)

CRISPR/Cas9 Technology and Its Utility for Crop Improvement
by: Hua Liu, et al.
Published: (2022-09-01)

CRISPR/Cas9: a tool to eradicate HIV-1
by: Ruchira Bhowmik, et al.
Published: (2022-12-01)

CRISPR/Cas9-based genome engineering in HIV gene therapy
by: Tang Xuanting
Published: (2021-01-01)

Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease
by: Monique E Maubert, et al.
Published: (2016-01-01)

Extracellular HIV-1 Tat Mediates Increased Glutamate in the CNS Leading to Onset of Senescence and Progression of HAND
by: Jamie Marino, et al.
Published: (2020-06-01)

Viral quasispecies.
by: Esteban Domingo, et al.
Published: (2019-10-01)

Mild cognitive impairment in a clinically latent HIV-1 patient population
by: K.N. Devlin, et al.
Published: (2015-12-01)

CRISPR/Cas9 in Gastrointestinal Malignancies
by: André Jefremow, et al.
Published: (2021-11-01)

Targeting TRIM5 alpha in HIV cure strategies for the CRISPR-Cas9 era
by: Weatherley, D, et al.
Published: (2017)

Construction of Lipopolysaccaride Binding Protein Knockout Mice Using CRISPR/Cas9 Technology
by: LI Sidi, et al.
Published: (2022-08-01)

Combinatorial Crispr/Cas9 For Suppression Of Latent Hiv-1 Provirus In Vitro
by: Ravichantar, Nithya
Published: (2020)